• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • palopegteriparatide
    1 Drug classified under this active ingredient


    All the Active Ingredient Drugs

    YORVIPATH
    Neopharm (Israel) 1996 Ltd.
    RX
    not in the basket chart
    YORVIPATH

    Parathyroid hormone analogue. palopegteriparatide 0.3 mg/ml.
    pre -filled pen2 X 1.4/0.56/0.98 ml  sol for SC inj.
    Starting dose is 18 mcg once /d with dose adjustments in 3 mcg increm. thereafter every 7 days. The dose range is 6 to 60 mcg/d. Serum calcium concentr. must be monitored during titrat. Mainten. dose should be dose that achieves serum calcium within normal range, without need for active vit D or therap. doses of calcium. See full prescr. info.
    Parathyroid hne.(PTH) replacement ther. for adults with chronic hypoparathyroidism
    C/I:
      Hypersens.- pseudohypoparathyroidism

    CLOSE